Cite
HARVARD Citation
Ianotto, J. et al. (n.d.). Biosimilars of filgrastim in autologous stem cell transplant: reduction in granulocyte-colony stimulating factor costs, but similar effects on bone marrow recovery. Leukemia & lymphoma. 55 (1), pp. 74-77. [Online].